Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 1—January 2017
Research

Modeling Tool for Decision Support during Early Days of an Anthrax Event

Gabriel RainischComments to Author , Martin I. Meltzer1, Sean Shadomy, William A. Bower, and Nathaniel Hupert1
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (G. Rainisch, M.I. Meltzer, S. Shadomy, W.A. Bower, N. Hupert); Weill Cornell Medical College and New York–Presbyterian Hospital, New York, New York, USA (N. Hupert)

Main Article

Figure 1

Anthrax Assist model disease stages, intervention states, and transitions. Persons begin in the top Incubation state and may transition via the numbered arrows from one state to another until they eventually reach an outcome state (doubled-walled boxes). All persons with untreated infection will progress to deceased. Recovery is possible only through effective oral PEP (averted case) or anthrax-specific treatment (recovered). Transitions are governed by the 3 Anthrax Assist models as follows: Ep

Figure 1. Anthrax Assist model disease stages, intervention states, and transitions. Persons begin in the top Incubation state and may transition via the numbered arrows from one state to another until they eventually reach an outcome state (doubled-walled boxes). All persons with untreated infection will progress to deceased. Recovery is possible only through effective oral PEP (averted case) or anthrax-specific treatment (recovered). Transitions are governed by the 3 Anthrax Assist models as follows: Epidemic-Curve model, transition 1; PEP Impact model, transitions 2 and 3; Healthcare Impact model, transitions 4–11. Suspected, but Not Actually Exposed cases are shown here because of their role in diluting the incubating population seeking PEP (dashed transition arrow). PEP and Treatment queues (dashed outline boxes) are depicted to reflect the necessary interactions persons must have with the public health and healthcare systems to transition between treatment states. PEP, postexposure prophylaxis.

Main Article

1These senior authors contributed equally to this article.

Page created: December 14, 2016
Page updated: December 14, 2016
Page reviewed: December 14, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external